Eli Lilly’s phase 3 ADorable-1 trial of Ebglyss in paediatric patients with moderate-to-severe atopic dermatitis meets primary and key secondary endpoints: Indianapolis Tuesday, ...
ORKA-001 EVERLAST-A 16-week data now expected in 2Q 2026 following rapid enrollment, with longer-term follow-up data expected in 2H ...
Thousands of Oklahomans evacuated Sunday as wildfires spread across the state, fueled by strong winds and high temps. Here's what to expect Monday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results